“Right now, there is exciting and growing evidence to suggest that the microbiota are associated with some diseases of the brain. However, more work is still needed.” says Dr. Tremlett. “One real challenge will be to prove a causative link.”
You are hereNews & Events
According to new research from Dr. Jacqueline Quandt, published recently in Brain, Behaviour and Immunity, a simple compound shows promise in altering immune responses without eliminating cells and in doing so protects the cells in the nervous system and prevents the underlying neurodegeneration in models of MS.
A new physician-engagement initiative is coming to UBC Hospital and the Djavad Mowafaghian Centre for Brain Health.
The initiative’s goal is to involve physicians working in acute care facilities as true partners in the healthcare decision-making process, and help generate improvements that will make our future BC healthcare system sustainable. Without involving physicians, achieving better patient care, and better community health at the lowest cost possible will remain elusive goals.
On the first floor of the Djavad Mowafaghian Centre for Brain Health, a massive, two decade-long project has been quietly underway for the past three years. The Vancouver Data Collection Site for the Canadian Longitudinal Study on Aging (CLSA) is based here, and Dr. Heather Stewart and her team are returning to the Centre to start the first follow-up after 18 months collecting data at SFU Surrey’s CLSA data collection site.
New research from MSFHR trainee Jose Wijnands (PI: Dr. Helen Tremlett) fills knowledge gaps and establishes a baseline for understanding infection risk for people with multiple sclerosis (MS) relative to those without MS.
In order to effectively use brain imaging to diagnose diseases, physicians and other healthcare professionals need to know what they are looking at. New guidelines co-authored by MRI scientist and physicist Dr. Alex Rauscher, published recently in Nature Reviews Neurology, may improve the process of diagnosis for multiple sclerosis (MS).
The mutation was found in two Canadian families that had several members diagnosed with a rapidly progressive type of MS, in which a person’s symptoms steadily worsen and for which there is no effective treatment.
For patients with Parkinson disease (PD), cognitive decline can be one of the most debilitating symptoms of the condition. As many as 80 per cent of people with PD experience some form of cognitive impairment, with up to a quarter of patients presenting symptoms of memory loss or impairment at diagnosis.
Bacteria in the guts of children who had recently developed multiple sclerosis (MS) differed from healthy control children, finds new research from Dr. Helen Tremlett and her University of California research colleagues, including co-PI Dr. Emmanuelle Waubant. These differences were suggestive of a pro-inflammatory environment within the gut bacterial community of the children with MS.